FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder ...Middle East

SILVER SPRING, Md., Nov. 9, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on‑demand enzyme replacement therapy (ERT) in adult and pediatric...

Hence then, the article about fda approves first treatment for patients with rare inherited blood clotting disorder was published today ( Thursday 09/11/2023 - 10:44 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder )

Also on site :

• The ‘imminent’ oil crisis isn’t at the pump—it’s under your hood
• DJI presenta los resultados de la evaluación de seguridad independiente más completa de sus sistemas de drones
• Infighting, court battles could put long-hyped air taxi breakthrough in jeopardy